alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
1... The Honorable Brenda Chapman presided over the motion to set aside the information. The Honorable Al

Alonso signed the judgment. 

i i i i i i

CONCURRING OPINION

No. 04-08-00547-CR

Anthony Joseph HERRERA,

Appellant

v.

The STATE of Texas,

Appellee

From the County Court at Law No.1, Bexar County, Texas

Trial Court No. 232454

Honorable Al Alonso, Judge Presiding1

Opinion by: Karen Angelini, Justice

Concurring opinion by: Sandee Bryan Marion, Justice

Sitting: Karen Angelini, Justice

Sandee Bryan Marion, Justice

Phylis J. Speedlin, Justice

Delivered and Filed: July 29, 2009

I concur in the majority’s judgment; however, for the reasons set forth in my concurring

opinion in Urdiales v. State, No. 04-08-00546-CR, 2009 WL 1883932 (Tex. App.—San Antonio

July 1, no pet. h.), I urge the Legislature to amend its definition of “race” because the “statutory
Concurring Opinion 04-08-00547-CR

-2-

definition places an ordinary law-abiding person into the position of committing an offense, even

if he is otherwise observing the speed limit, simply by using his vehicle to pass another vehicle.”

Id. at *5.

Sandee Bryan Marion, Justice

DO NOT PUBLISH
October 26, 2015 

Dear Mr. Backmann: 

This letter is to inform you that the following information is missing from your petition 

(Docket No. FAA−2015−2787). This information is necessary for the Federal Aviation 

Administration (FAA) to process your petition. 

 Provide a copy of the Motion Picture and Television Operations Manual (MPTOM) 

which is required by Order 8900.1, Volume 3, Chapter 8, Section 1. If you wish for us to 

proceed without this manual and remove closed-set filming from your proposed operation 

please inform of us of your intention by the requested response date listed below. 

Please submit the additional information (non-proprietary) to your docket at 

www.regulations.gov and submit any proprietary information to the FAA Headquarters or 

electronically via email to 333exemptions@faa.gov. If you want us to process your request any 

further, we must receive the information described above by 11/9/15. If we do not receive the 

information, we will close the docket without notifying you further. 

If you have any questions, please feel free to contact me at (202) 267-4712. 

Sincerely, 

/s/ 

Brenda Robeson 

Program Analyst
§ 522.1503 Neostigmine. ( a ) *Specifications.* Each milliliter of solution contains 2 milligrams (mg) neostigmine methylsulfate.
( b ) *Sponsor.* See No. 000061 in § 510.600(c) of this chapter.
( c ) *Conditions of use* — ( 1 ) *Amount.* Administer to cattle and horses at a dosage level of 1 mg per (/) 100 pounds (lbs) of body weight subcutaneously. Administer to sheep at a dosage level of 1 to 11 ⁄ 2 mg/100 lbs body weight subcutaneously. Administer to swine at a dosage level of 2 to 3 mg/100 lbs body weight intramuscularly. These doses may be repeated as indicated.
( 2 ) *Indications for use.* For treating rumen atony; initiating peristalsis which causes evacuation of the bowel; emptying the urinary bladder; and stimulating skeletal muscle contractions.
( 3 ) *Limitations.* Not for use in animals producing milk, since this use will result in contamination of the milk. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[40 FR 13858, Mar. 27, 1975, as amended at 62 FR 61625, Nov. 19, 1997; 79 FR 16192, Mar. 25, 2014]
NO. 07-05-0435-CR

	IN THE COURT OF APPEALS

	FOR THE SEVENTH DISTRICT OF TEXAS

	AT AMARILLO

	PANEL C

	AUGUST 15, 2006

	______________________________

	THE STATE OF TEXAS, APPELLANT

	V.

	ADNEY SADAKHOUNE, APPELLEE

	_________________________________

	FROM THE 108TH DISTRICT COURT OF POTTER COUNTY;

	NO. 49,107-E; HONORABLE ABE LOPEZ, JUDGE

	_______________________________

Before QUINN, C.J., and REAVIS and HANCOCK, JJ.

	ABATEMENT AND REMAND

	After the trial court adjudicated appellee Adney Sadakhoune guilty of soliciting membership in a street gang, he filed a motion for new trial and motion in arrest of judgment, which the trial court granted on February 8, 2006.  The State filed this accelerated appeal.  The appellate record and State’s brief have both been filed.  Appellee’s appointed counsel, Cynthia J. Barela, has failed to file a brief in his behalf despite being granted three extensions of time.

	The State’s brief was filed on April 13, 2006, and appellee’s brief was initially due to be filed on May 15, 2006.  By her first and second motions for extension of time, counsel indicated she had excessive court appearances that prevented her from devoting sufficient time to research and prepare a brief.  In her third motion, counsel again indicated she had insufficient time to research and prepare a brief and was scheduled to be on vacation from June 29, 2006, through July 6, 2006.  Resultantly, a final extension in which to file appellee’s brief was granted to July 14, 2006.  To date, counsel has not communicated with this Court nor filed appellee’s brief.

	In the interest of justice, we abate this appeal and remand the cause to the trial court for further proceedings.  Given the accelerated nature of this appeal, upon remand, the trial court shall immediately cause notice of a hearing to be given and, thereafter, conduct a hearing to determine the following:  

	1.	whether appellee has been denied effective assistance of counsel given counsel’s failure to file a brief after leaving the impression by her motions for extension of time that she intended to do so and, if so, 									

	2.	whether appellee is entitled to new appointed counsel for representation in this accelerated appeal.									

The trial court shall cause a hearing to be transcribed.  Should it be determined that appellee’s counsel should be replaced, the name, address, telephone number, and state bar number of newly-appointed counsel shall be provided to the Clerk of this Court.  Finally, the trial court shall execute findings of fact, conclusions of law, and any necessary orders it may enter regarding the aforementioned issues and cause its findings and conclusions to be included in a supplemental clerk's record.  A supplemental record of the hearing shall also be included in the appellate record.  Finally, the trial court shall file the supplemental clerk's record and the supplemental reporter's record with the Clerk of this Court by Friday, September 1, 2006.

	It is so ordered.

		Per Curiam

Do not publish.
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

JUAN ANTONIO GUTIERREZ

,

Appellant

,

v.

THE STATE OF TEXAS

,

State

. §

§

§

§

§

§

§ No. 08

- 1 8

- 00 194

- C R

Appeal from the

41 st District C ourt

of El Paso C ounty, Texas

(TC# 201 40D03047 )

O R D E R

The Court GRANTS the Appellant’s fourth m otion for extension of time within which to

file the brief until Ju ly 19 , 201 9

. NO FURTHER MOTIONS FOR EXTENSION OF TIME TO

F ILE THE APPELLANT ’S BR IEF WILL BE CONSIDERED BY THIS COURT.

It is further ORDERED that the Hon. Veronica Teresa Lerma

, the Appellant ’s attorney,

prepare the Appellant ’s brief and forward the same to this Court on or before Ju ly 19 , 2019

.

IT IS SO ORDERED this 7 th day of June , 20 1 9

.

PER CURIAM

Before McCl ure, C.J., Rodriguez, and Palafox , JJ.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 97-7038

WINSTON LLOYD,

Plaintiff - Appellant,

versus

RICHARD LANHAM, Commissioner of Corrections;

MELANIE PEREIRA, Deputy Commissioner of

Corrections; EARL BESHEARS, Warden; GLENN T.

MARROW, Assistant Attorney General, all defendants sued individually and in their official

capacity; DOCTOR SEIFERT, sued individually

and in her official capacity,

Defendants - Appellees.

Appeal from the United States District Court for the District of

Maryland, at Greenbelt. Peter J. Messitte, District Judge. (CA97-127-PJM. CA-97-32-PJM)

Submitted: March 26, 1998 Decided: April 7, 1998

Before WIDENER and MOTZ, Circuit Judges, and BUTZNER, Senior

Circuit Judge.

Affirmed by unpublished per curiam opinion.

Winston Lloyd, Appellant Pro Se. John Joseph Curran, Jr., Attorney

General, Glenn William Bell, OFFICE OF THE ATTORNEY GENERAL OF

MARYLAND, Baltimore, Maryland, for Appellees.
2

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).

PER CURIAM:

Appellant appeals from the district court's order denying

relief on his consolidated 42 U.S.C. § 1983 (1994) complaints. We

have reviewed the record and the district court's opinion and find

no reversible error. Accordingly, we affirm on the reasoning of the

district court. Lloyd v. Lanham, Nos. CA-97-127-PJM; CA-97-32-PJM

(D. Md. June 26, 1997). We dispense with oral argument because the

facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional

process.

AFFIRMED
OAR Box 1490 

Prepped by Charmelle Mathews 

Document Number: 

46) IV-C-19 

Docket Number: 

A-94-52 

Printed 8/4/2008 11:51:47 AM Sheet 46 of 273 

P.1 
P.2 

A-94-52 

IV-C-19 

Keith Barnett 

4 02/27/2002 09:04 AM 

To: John Schweitzer <jschwtzr@gte.net> 

cc: 

Subject: Re: Determining HAP contentS 

I talked to Mark and reviewed the text in the Boat Manufacturing rule. I don't see any reason we couldn't 

adopt most of their language on organic HAP content determination. 

Keith W. Barnett 

US/EPA OAQPS, ESD/MICG C504-05 

Research Triangle Park, NC 27711 

919-541-5605 

barnett.keith@epa.gov 

John Schweitzer <jschwtzr@gte.net> 

To: Keith Barnett/RTP/USEPA/US@EPA 

cc: 

Subject: Determining HAP content 

Keith, in Section V.R. (page 76) of ouNComments, wedsked you to consider adoption ofthe same 

provisions as used in the boat rule for sources to^pSe in determining the HAP content of resin and gel 

coat. 

know ifyou will make the change as we suggested? 

FROM 

John Schweitzi 

Sr. Director of Gov't. Affairs 

Composites Fabricators Assoc 

voice 734.622.0162 

fax 7*4.622.0122 

ischwtzr@ate.net 

www.cfa-hq.oro
1

COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER

Appellate case name: Xochytl Greer v. Wesley Michael Melcher

Appellate case number: 01-19-00287-CV

Trial court case number: 2017-41808

Trial court: 245th District Court of Harris County

Appellant, Xochytl Greer, has filed a motion for review of the trial court’s order 

sustaining the court reporter’s contest to appellant’s statement of inability to pay costs. See 

TEX. R. CIV. P. 145(g)(1). Because the trial court signed the order on May 3, 2019, 

appellant’s motion was due to be filed no later than May 13, 2019. See TEX. R. CIV. P.

145(g)(2). Appellant, however, filed her motion in this Court on May 14, 2019.

We may extend the deadline for filing a motion challenging an order under rule 145 

“by 15 days if [appellant] demonstrates good cause for the extension in writing.” TEX. R.

CIV. P. 145(g)(2). Accordingly, we direct appellant to provide a written response to this 

order that “demonstrates good cause” to extend the deadline for filing her motion for 

review of the trial court’s May 3, 2019 order. Appellant’s response is due no later than 

7 days from the date of this order.

It is so ORDERED.

Judge’s signature: /s/ Julie Countiss

  Acting individually  Acting for the Court

Date: __May 21, 2019___
§ 573.280 Feed-grade calcium stearate and sodium stearate. Feed-grade calcium stearate and sodium stearate may be safely used in an animal feed in accordance with the following prescribed conditions: ( a ) Feed-grade calcium stearate and sodium stearate are the calcium or sodium salts of a fatty acid mixture that is predominately stearic acid. Associated fatty acids, including palmitic acid and minor amounts of lauric, myristic, pentadecanoic, margaric, arachidic, and other fatty acids may be contained in the mixture, but such associated fatty acids in aggregate do not exceed 35 percent by weight of the mixture. The fatty acids may be derived from feed-grade fats or oils.
( b ) The additives meet the following specifications: ( 1 ) Unsaponifiable matter does not exceed 2 percent.
( 2 ) They are free of chick-edema factor.
( c ) The additives are manufactured so that in aqueous solution they are exposed for 1 hour or longer to temperature in excess of 180 °F.
( d ) They are used as anticaking agents in animal feeds in accordance with current good manufacturing practices.
[63 FR 8573, Feb. 20, 1998]
```

[Federal Register Volume 75, Number 38 (Friday, February 26, 2010)]
[Notices]
[Page 9004]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4103]

=======================================================================
-----------------------------------------------------------------------

OVERSEAS PRIVATE INVESTMENT CORPORATION

Sunshine Act; Board of Directors Meeting

TIME AND DATE: Wednesday, March 31, 2010, 9:30 a.m. (OPEN Portion); 
9:45 a.m. (CLOSED Portion).

PLACE: Offices of the Corporation, Twelfth Floor Board Room, 1100 New 
York Avenue, NW., Washington, DC.

STATUS:  Meeting OPEN to the Public from 9:30 a.m. to 9:45 a.m. Closed 
portion will commence at 9:45 a.m. (approx.)

MATTERS TO BE CONSIDERED: 
    1. President's Report.
    2. Approval of November 19, 2009 Minutes (Open Session).

FURTHER MATTERS TO BE CONSIDERED:  (Closed to the Public 9:45 a.m.)
    1. Finance Project--Turkey.
    2. Finance Project--Ghana.
    3. Finance Project--Panama.
    4. Finance Project--Russia.
    5. Finance Project--Jordan.
    6. Finance Project--Afghanistan.
    7. Finance Project--Afghanistan.
    8. Finance Project--Iraq.
    9. Finance Project--OPIC-eligible countries in Africa, Europe, and 
Newly Independent States.
    10. Finance Project--Africa.
    11. Finance Project--India and other OPIC-eligible Asian countries.
    12. Finance Project--Nigeria, Ghana, Kenya, Angola, South Africa, 
Ivory Coast, Tanzania and Uganda.
    13. Finance Project--OPIC-eligible countries in Asia.
    14. Approval of November 19, 2009 Minutes (Closed Session).
    15. Pending Major Projects.
    16. Reports.
    Written summaries of the projects to be presented will be posted on 
OPIC's Web site on or about February 24, 2010.

CONTACT PERSON FOR INFORMATION: Information on the meeting may be 
obtained from Connie M. Downs at (202) 336-8438.

    February 24, 2010.
Connie M. Downs,
Corporate Secretary, Overseas Private Investment Corporation.
[FR Doc. 2010-4103 Filed 2-24-10; 11:15 am]
BILLING CODE 3210-01-P
```
Exhibit 32.1

                  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350

         In connection with the accompanying Quarterly Report on Form 10-QSB of
Velocity Asset Management Inc. for the three months ended March 31, 2005, I,
John C. Kleinert, Chief Executive Officer of Velocity Asset Management, Inc.
hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and
belief, that:

         (1)  such Quarterly Report on Form 10-QSB for the three months ended
         March 31, 2005, fully complies with the requirements of section 13(a)
         or 15(d) of the Securities Exchange Act of 1934; and

         (2)  the information contained in such Quarterly Report on Form 10-QSB
         for the three months ended March 31, 2005, fairly presents, in all
         material respects, the financial condition and results of operations of
         Velocity Asset Management, Inc.


                                       /s/ JOHN C. KLEINERT
                                       -----------------------------------------
                                       John C. Kleinert
                                       Chief Executive Officer


May 19, 2005

                                       26
§ 520.955 Florfenicol. ( a ) *Specifications.* Each milliliter (mL) contains 23 milligrams (mg) florfenicol.
( b ) *Sponsors.* See Nos. 000061, 054925, and 058198 in § 510.600(c) of this chapter.
( c ) *Related tolerances.* See § 556.283 of this chapter.
( d ) *Conditions of use in swine* — ( 1 ) *Amount.* Administer in drinking water *ad libitum* at 400 mg per gallon (100 parts per million (ppm)) for 5 consecutive days.
( 2 ) *Indications for use.* For the treatment of swine respiratory disease (SRD) associated with *Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella choleraesuis* and *Streptococcus suis.*
( 3 ) *Limitations.* Do not slaughter within 16 days of last treatment. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[67 FR 78357, Dec. 24, 2002, as amended at 72 FR 262, Jan. 4, 2007; 78 FR 52854, Aug. 27, 2013; 82 FR 12169, Mar. 1, 2017]
[Federal Register Volume 75, Number 37 (Thursday, February 25, 2010)]
[Notices]
[Page 8789]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-3874]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Research Advisory Committee on Gulf War Veterans' Illnesses; 
Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under Public 
Law 92-463 (Federal Advisory Committee Act) that the Research Advisory 
Committee on Gulf War Veterans' Illnesses will meet on March 1-2, 2010, 
in room 230 at the Department of Veterans Affairs, 810 Vermont Avenue, 
NW., Washington, DC. The meeting will be open to the public and it will 
start at 8 a.m. each day and will adjourn at 5 p.m. on March 1 and at 
1:15 p.m. on March 2.
    The purpose of the Committee is to provide advice and make 
recommendations to the Secretary of Veterans Affairs on proposed 
research studies, research plans and research strategies relating to 
the health consequences of military service in the Southwest Asia 
theater of operations during the Gulf War.
    The Committee will review VA program activities related to Gulf War 
veterans' illnesses and updates on relevant scientific research 
published since the last Committee meeting. Additionally, there will be 
presentations and discussion of background information on the Gulf War 
and Gulf War Veterans' illnesses, chronic pain, potential health 
effects of exposure to sarin, chronic fatigue syndrome, a planned 
survey of the health status of Norwegian Gulf War Veterans, and updates 
on a number of ongoing research at the University of Texas Southwestern 
Medical Center and the VA War Related Illness and Injury Centers. There 
will also be discussion of Committee business and activities.
    The meeting will include time reserved for public comments. A sign-
up sheet for five-minute comments will be available at the meeting. 
Individuals who speak are invited to submit a 1-2 page summary of their 
comments at the time of the meeting for inclusion in the official 
meeting record. Members of the public may also submit written 
statements for the Committee's review to Dr. Roberta White, Chair, 
Department of Environmental Health, Boston University School of Public 
Health, 715 Albany St., T2E, Boston, MA 02118.
    Any member of the public seeking additional information should 
contact Dr. White, Scientific Director, at (617) 638-4620 or Dr. 
William Goldberg, Designated Federal Officer, at (202) 461-1667.

    Dated: February 22, 2010.

    By Direction of the Secretary.
Vivian Drake,
Acting Committee Management Officer.
[FR Doc. 2010-3874 Filed 2-22-10; 8:45 am]
BILLING CODE 8320-01-P
§ 582.5676 Pyridoxine hydrochloride. ( a ) *Product.* Pyridoxine hydrochloride.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
# C_2014223EN.01000601.xml

| 14.7.2014 | EN | Official Journal of the European Union | C 223/6 |
| --- | --- | --- | --- |

14.7.2014

EN

Official Journal of the European Union

C 223/6

---

Request for a preliminary ruling from the Audiencia Provincial Navarra (Spain) lodged on 25 April 2014 — Antonia Valdivia Reche v Banco de Valencia, S.A.

(Case C-208/14)

2014/C 223/08

Language of the case: Spanish

Referring court

Referring court

Audiencia Provincial Navarra

Parties to the main proceedings

Parties to the main proceedings

Appellant: Antonia Valdivia Reche

Appellant:

Respondent: Banco de Valencia, S.A.

Respondent:

Question referred

Question referred

Does Article 6 of Directive 93/13 (1) require the national court, when it has found a term setting a rate of 29 % for default interest to be unfair, to declare that term ineffective, without any scope for reducing the rate of interest agreed, even though such a reduction has been expressly requested by one of the consumers against whom proceedings have been brought?

1

---

(1)  Council Directive 93/13/EEC of 5 April 1993 on unfair terms in consumer contracts (OJ 1993 L 95, p. 29).

1

---
Federal Depository Library ProgramPersistent URL Home Page      

# Target for /GPO/gpo120966 lost

The target resource for this PURL can no longer be traced. The following is a list of the targets this PURL was previously assigned to.

Powered by the Federal Depository Library Program.                A service of the U.S. Government Publishing Office.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                         837,832
<SECURITIES>                                         0
<RECEIVABLES>                                1,862,962
<ALLOWANCES>                                    10,000
<INVENTORY>                                  2,281,166
<CURRENT-ASSETS>                             6,917,163
<PP&E>                                      98,466,610
<DEPRECIATION>                              10,209,038
<TOTAL-ASSETS>                              96,061,824
<CURRENT-LIABILITIES>                        5,570,207
<BONDS>                                      9,729,571
<PREFERRED-MANDATORY>                       15,977,355
<PREFERRED>                                          0
<COMMON>                                        38,438
<OTHER-SE>                                  60,616,573
<TOTAL-LIABILITY-AND-EQUITY>                96,061,824
<SALES>                                      7,694,987<F1>
<TOTAL-REVENUES>                             7,694,987<F1>
<CGS>                                        6,140,847
<TOTAL-COSTS>                                8,470,033
<OTHER-EXPENSES>                              (15,300)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             181,458
<INCOME-PRETAX>                              (941,204)
<INCOME-TAX>                                 (225,888)
<INCOME-CONTINUING>                          (715,316)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (715,316)
<EPS-PRIMARY>                                   (0.09)
<EPS-DILUTED>                                   (0.09)
<FN>Sales and Total Revenue are net of federal 
    and state excise taxes.
</FN>
        


</TABLE>